Topic

NVS

A collection of 1 issue

Novartis Faces Legal Revival Over Gilenya Kickback Claims

Novartis is under scrutiny as a U.S. court revives a whistleblower lawsuit alleging kickbacks in promoting its MS drug, Gilenya. Impact on reputation and stock price likely.